Furthermore, although in Europe, uric acid is not considered an independent risk factor, the majority of interventional studies, even though on small cohorts, prove the benefits of xanthine oxidase inhibitors therapy in asymptomatic hyperuricemia. The gene discussed is XDH; the disease is hyperuricemia.